8-K

Company

X4 Pharmaceuticals, Inc

Filed

August 25, 2025

Period of Report

August 22, 2025

Accession Number

0001501697-25-000008

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →